Sexual MedicineEvaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5 mg and 10 mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

This drug is indicated for treatment of erectile dysfunction, for signs and symptoms of benign prostate hyperplasia in male adult patients, and is also marketed as Adcirca (R) for the treatments of pulmonary arterial hypertension (PAH). Patients who experience cardiovascular symptoms upon initiation of sexual activity should refrain from further sexual activity and seek immediate medical attention.

Side Effect	Percentage of Users	Severity	Onset Time
Headache	20%	Mild to moderate	Within 1 hour
Flushing	15%	Mild	Within 1-2 hours
Nasal Congestion	10%	Mild	Within a few hours
Muscle Pain	5%	Mild	Variable

Patients taking this drug for erectile dysfunction should not take Adcirca (R) or other PDE5 inhibitors.

• Tadalafil 10mg is typically taken once every 24 hours for continuous effect.
• It’s crucial to report any allergic reactions, such as rash or swelling, to your doctor.
• Combining tadalafil with certain medications can cause dangerous drops in blood pressure.
• Regular medical check-ups help ensure the safe use of tadalafil 10mg daily.

Patients should seek emergency treatment if an erection, whether painful or not, lasts more than 4 hours.

Can you take tadalafil daily? Key takeaways

Patients should seek immediate medical attention in the event of a sudden loss of vision in one or both eyes while taking this drug.

Product	Dosage	Quantity + Bonus	Price
Cialis Generic	2.5mg	360 + 10 Pills	260.03€ 247.65€	Buy
Cialis Generic	20mg	60 + 6 Pills	117.76€ 112.15€	Buy
Cialis Generic	2.5mg	90 + 6 Pills	112.43€ 107.08€	Buy
Cialis Generic	20mg	30 + 4 Pills	68.05€ 64.81€	Buy
Cialis Generic	20mg	360 + 10 Pills	427.34€ 406.99€	Buy
Tadalista Super Active	20mg	270 + 30 Pills	661.49€ 629.99€	Buy
Cialis Generic	40mg	180 + 10 Pills	277.29€ 264.09€	Buy
Cialis Generic	40mg	20 Pills	59.47€ 56.64€	Buy
Cialis Generic	10mg	360 + 10 Pills	388.49€ 369.99€	Buy
Tadalista Super Active	20mg	180 + 20 Pills	521.59€ 496.75€	Buy
Cialis Generic	5mg	270 + 10 Pills	205.81€ 196.01€	Buy
Cialis Generic	60mg	120 + 8 Pills	240.18€ 228.74€	Buy
Cialis Generic	60mg	180 + 10 Pills	313.11€ 298.20€	Buy
Cialis Generic	5mg	10 Pills	29.39€ 27.99€	Buy

Patients should seek immediately medical attention in the event of sudden decrease or loss of hearing while taking this drug. Tadalafil (Erectile Dysfunction, Benign Prostatic Hyperplasia) monograph Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. I am currently reviewing your question and will get back to you shortly. Typically, when Tadalafil is prescribed for daily use, a dosage of 2.5 sublingual tadalafil to 5 mg is recommended. However, research has indicated that a daily dose of 10 mg is also well tolerated, so I would consider it safe to use that amount, provided there are no underlying kidney or heart issues.

2 Methods

Stop tadalafil >24 hours prior to protease inhibitor (PI) initiation, restart 7 days after PI initiation at 20 mg once daily, and increase to 40 mg once daily based on tolerability. atazanavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ceritinibceritinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ceritinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. clarithromycinclarithromycin will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

4. How important is being spontaneous?

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

Please feel free to reach out if you have any additional questions, and I would be happy to discuss it further with you.

• Tadalafil 10mg is often preferred for its once-daily dosing convenience.
• Patients with certain medical conditions should not use tadalafil without medical advice.
• Tadalafil may cause a drop in blood pressure, especially with concomitant medications.
• Consistent daily use can lead to spontaneous erections, enhancing sexual spontaneity.

Disclaimer: The customer and expert messages presented herein may have been altered or modified to enhance readability and safeguard the privacy of individuals. These modifications do not change the intent or substance of the original messages. Indicated for treatment of erectile dysfunction (ED) Cialis (or generic equivalent) or Chewtadzy only PRN use: 10 mg PO initially before sexual activity, with or without food; may be increased to 20 mg or reduced to 5 mg on basis of efficacy and tolerability; in most patients, maximum dosing frequency is once daily Once-daily use (Cialis): 2.5 mg/day PO in single daily dose, without regard to timing of sexual activity, with or without food; may be increased to 5 mg/day on basis of efficacy and tolerability Indicated for treatment of signs and symptoms of benign prostatic hyperplasia (BPH); daily use also indicated for treatment of patients with both BPH and erectile dysfunction Cialis (or generic equivalent) or Chewtadzy only BPH with ED: 5 mg PO once daily, taken at approximately same time each day without regard to timing of sexual activity Coadministration with finasteride for BPH: Tadalafil 5 mg plus finasteride 5 mg PO once daily for ≤26 weeks; incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the benefit beyond 26 weeks is unknown Indicated for pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability; studies establishing effectiveness included predominately patients with NYHA Functional Class II – III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%) Adcirca, Alyq, Tadliq, or generic equivalent only 40 mg PO once daily; dividing dose for more frequent dosing is not recommended Patients also taking ritonavir: 20 mg PO once daily initially for ≥1 week; may be increased to 40 mg/day on basis of tolerability Cialis, Chewtadzy (PRN use)Mild (CrCl >50 mL/min): No dosage adjustment neededModerate (CrCl 30-50 mL/min): Not to exceed 5 mg PO once daily initially; maximum dosage, 10 mg PO q48hrSevere (CrCl <30 mL/min and on hemodialysis): Not to exceed 5 mg PO q72hr Mild (CrCl >50 mL/min): No dosage adjustment needed Moderate (CrCl 30-50 mL/min): Not to exceed 5 mg PO once daily initially; maximum dosage, 10 mg PO q48hr Severe (CrCl <30 mL/min and on hemodialysis): Not to exceed 5 mg PO q72hr Cialis (once daily use)ED (CrCl >50 mL/min): No dosage adjustment neededBPH or BPH/ED (CrCl 30-50 mL/min): 2.5 mg/day starting dose recommended; may increase to 5 mg according to individual responseED or BPH (CrCl <30 mL/min or hemodialysis): Not recommended ED (CrCl >50 mL/min): No dosage adjustment needed BPH or BPH/ED (CrCl 30-50 mL/min): 2.5 mg/day starting dose recommended; may increase to 5 mg according to individual response ED or BPH (CrCl <30 mL/min or hemodialysis): Not recommended Chewtadzy (once daily use)BPH, ED/BPHCrCl >50 mL/min: No dosage adjustment neededCrCl ≤50 mL/min or hemodialysis: Not recommended CrCl >50 mL/min: No dosage adjustment needed CrCl ≤50 mL/min or hemodialysis: Not recommended Adcirca, Alyq, TadliqMild-to-moderate (CrCl 31-80 mL/min): 20 mg PO once daily initially; may be increased to 40 mg once daily on basis of tolerabilitySevere (CrCl <30 mL/min and on hemodialysis): Avoid use Mild-to-moderate (CrCl 31-80 mL/min): 20 mg PO once daily initially; may be increased to 40 mg once daily on basis of tolerability Severe (CrCl <30 mL/min and on hemodialysis): Avoid use Cialis, Chewtadzy (PRN use)Mild-to-moderate (Child-Pugh class A or B): Not to exceed 10 mg PO once dailySevere (Child-Pugh class C): Not recommended Mild-to-moderate (Child-Pugh class A or B): Not to exceed 10 mg PO once daily Severe (Child-Pugh class C): Not recommended Cialis, Chewtadzy (once daily use)Mild-to-moderate (Child-Pugh class A or B): Data limited; caution advisedSevere (Child-Pugh class C): Not recommended Mild-to-moderate (Child-Pugh class A or B): Data limited; caution advised Severe (Child-Pugh class C): Not recommended Adcirca, Alyq, TadliqMild-to-moderate (Child-Pugh class A or B): Consider starting dosage of 20 mg PO once dailySevere (Child-Pugh class C): Avoid use Mild-to-moderate (Child-Pugh class A or B): Consider starting dosage of 20 mg PO once daily Severe (Child-Pugh class C): Avoid use ED PRN use: Not to exceed 10 mg/72 hr ED or ED/BPH once-daily use: Not to exceed 2.5 mg/day Adcirca, Alyq, TadliqOn ritonavir for at least 1 week: Start tadalafil at 20 mg PO qDay; may increase to 40 qDay based on individual tolerabilityAvoid tadalafil during ritonavir initiationStop tadalafil at least 24 hr before to starting ritonavirAfter at least 1 week following ritonavir initiation, resume tadalafil 20 mg PO qDay; may increase to 40 qDay based on individual tolerability On ritonavir for at least 1 week: Start tadalafil at 20 mg PO qDay; may increase to 40 qDay based on individual tolerability Stop tadalafil at least 24 hr before to starting ritonavir After at least 1 week following ritonavir initiation, resume tadalafil 20 mg PO qDay; may increase to 40 qDay based on individual tolerability Chewtadzy: Not indicated for once daily use for ED because dosing is not possible (recommended dosage for this indication cannot be achieved with lowest available strength) Orphan designation for Duchenne muscular dystrophy (DMD) Eli Lilly and Company; Lilly Corporate Center; Indianapolis, IN 46285 Indicated for treatment of erectile dysfunction (ED) Cialis or generic equivalent only: No dosage adjustment is warranted solely on basis of age; however, greater sensitivity to medications in some older individuals should be considered Indicated for pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability; studies establishing effectiveness included predominately patients with NYHA Functional Class II – III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%) Adcirca, Alyq, or generic equivalent only: Lower dose or reduced dosing frequency may be required in elderly because of decreased renal or hepatic clearance Allow 48h after last tadalafil dose before nitrate administration.

Condition	Caution Required	Why
Nitrates Medication Use	Yes	Risk of severe hypotension
Severe Liver Impairment	Yes	Altered drug metabolism
Pulmonary Hypertension	No	Approved indication
Recent Stroke or Heart Attack	Caution	Cardiovascular risk

Allow 48h after last tadalafil dose before nitrate administration. nitroglycerin rectaltadalafil increases effects of nitroglycerin rectal by additive vasodilation.

Common Side Effects of Tadalafil

nitroglycerin rectaltadalafil increases effects of nitroglycerin rectal by additive vasodilation. Use of nitroglycerin within a few days of PDE5 inhibitors is contraindicated. PDE5 inhibitors have been shown to potentiate the hypotensive effects of organic nitrates. tadalafil increases effects of nitroglycerin rectal by additive vasodilation. Either increases effects tadalafil 40mg of the other by additive vasodilation.

5. Are you having side effects from another medication?

Coadministration of PDE-5 inhibitors (eg, avanafil, sildenafil, tadalafil, vardenafil) and guanylate cyclase stimulators (eg, riociguat) is contraindicated due to risk of additive hypotension; do not administer 24 hr before or within 48hr of each other. Either increases effects of the other by pharmacodynamic synergism. Coadministration of vericiguat with PDE-5 inhibitors may result in additive hypotensive effects. apalutamideapalutamide will decrease the level or effect of tadalafil sale tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration of apalutamide, a strong CYP3A4 inducer, with drugs that are CYP3A4 substrates can result in lower exposure to these medications.

Side effects and safety warnings for tadalafil

Avoid or substitute another drug for these medications when possible. Evaluate for loss of therapeutic effect if medication must be coadministered. Adjust dose according to prescribing information if needed. apalutamide will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. atazanaviratazanavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use of nitroglycerin within a few days of PDE5 inhibitors is contraindicated.

Adherence Rate	Reported Satisfaction	Reasons for Satisfaction	Common Complaints
85%	High	Improved erectile function	Mild headaches
78%	Moderate to High	Convenience of daily dosing	Flushing
65%	Variable	Effectiveness varies	Nasal congestion
90%	Very satisfied	Rapid onset, consistent results	None reported

PDE5 inhibitors have been shown to potentiate the hypotensive effects of organic nitrates. tadalafil increases effects of nitroglycerin rectal by additive vasodilation.

• Tadalafil 10mg helps men with erectile dysfunction achieve and maintain erections.
• It can also be used preventively for men who anticipate sexual activity regularly.
• Patients should avoid heavy alcohol to reduce the risk of side effects.
• Lifestyle changes, such as exercise and diet, can improve tadalafil’s effectiveness.

Either increases effects tadalafil 40mg of the other by additive vasodilation.

Why is this medication prescribed?

This drug is indicated for treatment of erectile dysfunction, for signs and symptoms of benign prostate hyperplasia in male adult patients, and is also marketed as Adcirca (R) for the treatments of pulmonary arterial hypertension (PAH). Patients who experience cardiovascular symptoms upon initiation of sexual activity should refrain from further sexual activity and seek immediate medical attention. Patients taking this drug for erectile dysfunction should not take Adcirca (R) or other PDE5 inhibitors. Patients should seek emergency treatment if an erection, whether painful or not, lasts more than 4 hours. Patients should seek immediate medical attention in the event of a sudden loss of vision in one or both eyes while taking this drug.

Use in Specific Populations

Patients should seek immediately medical attention in the event of sudden decrease or loss of hearing while taking this drug. Tadalafil (Erectile Dysfunction, Benign Prostatic Hyperplasia) monograph Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. I am currently reviewing your question and will get back to you shortly. Typically, when Tadalafil is prescribed for daily use, a dosage of 2.5 sublingual tadalafil to 5 mg is recommended. However, research has indicated that a daily dose of 10 mg is also well tolerated, so I would consider it safe to use that amount, provided there are no underlying kidney or heart issues.

Most Asked Questions

Please feel free to reach out if you have any additional questions, and I would be happy to discuss it further with you. Disclaimer: The customer and expert messages presented herein may have been altered or modified to enhance readability and safeguard the privacy of individuals. These modifications do not change the intent or substance of the original messages. Indicated for treatment of erectile dysfunction (ED) Cialis (or generic equivalent) or Chewtadzy only PRN use: 10 mg PO initially before sexual activity, with or without food; may be increased to 20 mg or reduced to 5 mg on basis of efficacy and tolerability; in most patients, maximum dosing frequency is once daily Once-daily use (Cialis): 2.5 mg/day PO in single daily dose, without regard to timing of sexual activity, with or without food; may be increased to 5 mg/day on basis of efficacy and tolerability Indicated for treatment of signs and symptoms of benign prostatic hyperplasia (BPH); daily use also indicated for treatment of patients with both BPH and erectile dysfunction Cialis (or generic equivalent) or Chewtadzy only BPH with ED: 5 mg PO once daily, taken at approximately same time each day without regard to timing of sexual activity Coadministration with finasteride for BPH: Tadalafil 5 mg plus finasteride 5 mg PO once daily for ≤26 weeks; incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the benefit beyond 26 weeks is unknown Indicated for pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability; studies establishing effectiveness included predominately patients with NYHA Functional Class II – III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%) Adcirca, Alyq, Tadliq, or generic equivalent only 40 mg PO once daily; dividing dose for more frequent dosing is not recommended Patients also taking ritonavir: 20 mg PO once daily initially for ≥1 week; may be increased to 40 mg/day on basis of tolerability Cialis, Chewtadzy (PRN use)Mild (CrCl >50 mL/min): No dosage adjustment neededModerate (CrCl 30-50 mL/min): Not to exceed 5 mg PO once daily initially; maximum dosage, 10 mg PO q48hrSevere (CrCl <30 mL/min and on hemodialysis): Not to exceed 5 mg PO q72hr Mild (CrCl >50 mL/min): No dosage adjustment needed Moderate (CrCl 30-50 mL/min): Not to exceed 5 mg PO once daily initially; maximum dosage, 10 mg PO q48hr Severe (CrCl <30 mL/min and on hemodialysis): Not to exceed 5 mg PO q72hr Cialis (once daily use)ED (CrCl >50 mL/min): No dosage adjustment neededBPH or BPH/ED (CrCl 30-50 mL/min): 2.5 mg/day starting dose recommended; may increase to 5 mg according to individual responseED or BPH (CrCl <30 mL/min or hemodialysis): Not recommended ED (CrCl >50 mL/min): No dosage adjustment needed BPH or BPH/ED (CrCl 30-50 mL/min): 2.5 mg/day starting dose recommended; may increase to 5 mg according to individual response ED or BPH (CrCl <30 mL/min or hemodialysis): Not recommended Chewtadzy (once daily use)BPH, ED/BPHCrCl >50 mL/min: No dosage adjustment neededCrCl ≤50 mL/min or hemodialysis: Not recommended CrCl >50 mL/min: No dosage adjustment needed CrCl ≤50 mL/min or hemodialysis: Not recommended Adcirca, Alyq, TadliqMild-to-moderate (CrCl 31-80 mL/min): 20 mg PO once daily initially; may be increased to 40 mg once daily on basis of tolerabilitySevere (CrCl <30 mL/min and on hemodialysis): Avoid use Mild-to-moderate (CrCl 31-80 mL/min): 20 mg PO once daily initially; may be increased to 40 mg once daily on basis of tolerability Severe (CrCl <30 mL/min and on hemodialysis): Avoid use Cialis, Chewtadzy (PRN use)Mild-to-moderate (Child-Pugh class A or B): Not to exceed 10 mg PO once dailySevere (Child-Pugh class C): Not recommended Mild-to-moderate (Child-Pugh class A or B): Not to exceed 10 mg PO once daily Severe (Child-Pugh class C): Not recommended Cialis, Chewtadzy (once daily use)Mild-to-moderate (Child-Pugh class A or B): Data limited; caution advisedSevere (Child-Pugh class C): Not recommended Mild-to-moderate (Child-Pugh class A or B): Data limited; caution advised Severe (Child-Pugh class C): Not recommended Adcirca, Alyq, TadliqMild-to-moderate (Child-Pugh class A or B): Consider starting dosage of 20 mg PO once dailySevere (Child-Pugh class C): Avoid use Mild-to-moderate (Child-Pugh class A or B): Consider starting dosage of 20 mg PO once daily Severe (Child-Pugh class C): Avoid use ED PRN use: Not to exceed 10 mg/72 hr ED or ED/BPH once-daily use: Not to exceed 2.5 mg/day Adcirca, Alyq, TadliqOn ritonavir for at least 1 week: Start tadalafil at 20 mg PO qDay; may increase to 40 qDay based on individual tolerabilityAvoid tadalafil during ritonavir initiationStop tadalafil at least 24 hr before to starting ritonavirAfter at least 1 week following ritonavir initiation, resume tadalafil 20 mg PO qDay; may increase to 40 qDay based on individual tolerability On ritonavir for at least 1 week: Start tadalafil at 20 mg PO qDay; may increase to 40 qDay based on individual tolerability Stop tadalafil at least 24 hr before to starting ritonavir After at least 1 week following ritonavir initiation, resume tadalafil 20 mg PO qDay; may increase to 40 qDay based on individual tolerability Chewtadzy: Not indicated for once daily use for ED because dosing is not possible (recommended dosage for this indication cannot be achieved with lowest available strength) Orphan designation for Duchenne muscular dystrophy (DMD) Eli Lilly and Company; Lilly Corporate Center; Indianapolis, IN 46285 Indicated for treatment of erectile dysfunction (ED) Cialis or generic equivalent only: No dosage adjustment is warranted solely on basis of age; however, greater sensitivity to medications in some older individuals should be considered Indicated for pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability; studies establishing effectiveness included predominately patients with NYHA Functional Class II – III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%) Adcirca, Alyq, or generic equivalent only: Lower dose or reduced dosing frequency may be required in elderly because of decreased renal or hepatic clearance Allow 48h after last tadalafil dose before nitrate administration. Allow 48h after last tadalafil dose before nitrate administration. Coadministration of PDE-5 inhibitors (eg, avanafil, sildenafil, tadalafil, vardenafil) and guanylate cyclase stimulators (eg, riociguat) is contraindicated due to risk of additive hypotension; do not administer 24 hr before or within 48hr of each other. Either increases effects of the other by pharmacodynamic synergism. Coadministration of vericiguat with PDE-5 inhibitors may result in additive hypotensive effects. apalutamideapalutamide will decrease the level or effect of tadalafil sale tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration of apalutamide, a strong CYP3A4 inducer, with drugs that are CYP3A4 substrates can result in lower exposure to these medications. Avoid or substitute another drug for these medications when possible. Evaluate for loss of therapeutic effect if medication must be coadministered. Adjust dose according to prescribing information if needed. apalutamide will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. atazanaviratazanavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stop tadalafil >24 hours prior to protease inhibitor (PI) initiation, restart 7 days after PI initiation at 20 mg once daily, and increase to 40 mg once daily based on tolerability. atazanavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ceritinibceritinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ceritinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. clarithromycinclarithromycin will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.